Chester County News and Community Website
MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …
Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More
WEST CHESTER, PA — Pathways Neuro Pharma, Inc., a Chester County-based biotechnology firm, has secured a U.S. patent for its groundbreaking neuroreceptor technology.
Pathways Neuro Pharma Clinches U.S. Patent for Pioneering Neuroreceptor Technology Read More
PHOENIXVILLE, PA — Health Cost Labs, a Pennsylvania-based healthcare analytics company, has launched a groundbreaking dashboard named Vindex, designed to give employers a new level of control over healthcare costs. …
Health Cost Labs Unveils Vindex: A Tool to Revolutionize Employer Healthcare Spending Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has launched a new series of inrush current limiting positive temperature coefficient (PTC) thermistors designed to enhance performance in active charge and …
Vishay Introduces High-Performing Thermistors for Automotive and Industrial Applications Read More
BERWYN, PA — Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V. (Nordic Pharma), has announced the appointment of leading ophthalmologist Dr. Eric D. Donnenfeld as Chair of its U.S. …
Amring Pharmaceuticals Appoints Renowned Ophthalmologist to Lead Advisory Board Ahead of Dry Eye Therapy Launch Read More MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) is making waves at the Applied Power Electronics Conference and Exposition (APEC) 2024 this week as it showcases a diverse portfolio of …
Vishay Intertechnology Flaunts Advanced Power Electronics Solutions at APEC 2024 Read More
MALVERN, PA — Venatorx Pharmaceuticals and Melinta Therapeutics recently received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) concerning their New Drug Application (NDA) for …
FDA Requests Additional Data for Venatorx and Melinta’s Antibiotic Combination Read More
WAYNE, PA — Neuraptive Therapeutics, Inc. has unveiled compelling 24-week data from its ongoing NEUROFUSE study on NTX-001, bolstering the product’s status after the positive proof of concept results based …
Neuraptive Therapeutics Reports Encouraging 24-Week Data for NTX-001 in NEUROFUSE Study Read More MALVERN, PA — Venatorx Pharmaceuticals, Melinta Therapeutics LLC, and the Menarini Group recently celebrated a significant medical breakthrough with the publication of the CERTAIN-1 Phase 3 clinical study results in …
Promising Phase 3 Results for Cefepime-Taniborbactam in Treating Complicated UTIs Read More
WEST CHESTER, PA — AccessLex Institute, a nonprofit organization committed to positively influencing legal education, is taking proactive steps to prepare law school students for the upcoming NextGen bar exam. …
AccessLex Institute Prepares for NextGen Bar Exam with Innovative Initiative Read More